Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?

BACKGROUND: Although active surveillance (AS) is a well-recognised treatment option for localised low-risk prostate cancer (LRPC), its role in the management of localised intermediate-risk prostate cancer (IRPC) is not clear yet and the available literature is slightly contradictory. OBJECTIVE: To c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Subhabrata, Promponas, Ioannis, Petrides, Neophytos, Hossain, Dafader, Abbaraju, Jayasimha, Madaan, Sanjeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317861/
https://www.ncbi.nlm.nih.gov/pubmed/34337491
http://dx.doi.org/10.1016/j.euros.2020.12.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317861/
https://www.ncbi.nlm.nih.gov/pubmed/34337491
http://dx.doi.org/10.1016/j.euros.2020.12.005

Ejemplares similares